Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20201210049671N1Phase 3Completed
Phase 3, single-blind trial of hyaluronic acid in atrophic acne scar (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Improvement grading of the lesions according to a dermatologist opinion, Improvement grading of lesions according to ultrasonic evaluation and 1 more. Started Mar 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20201210049671N1.